Summit Therapeutics Inc. Stock Performance
as on August 13, 2026 at 2:15 pm IST
Day's Low
Day's High
$14.99$15.75
0.73%
Downside
4.30%
Upside

52 Week's Low
52 Week's High
$12.25$30.05
18.87%
Downside
99.01%
Upside

Summit Therapeutics Inc. share price movements today
- Previous Close
- $15.12
- Open
- $15.41
- Volume
- 3.0M
- Day's Low - High
- $14.99 - $15.75
- 52 Week Low - High
- $12.25 - $30.05
Summit Therapeutics Inc. Historical Returns
- 1 Month Return
- -1.21 %
- 3 Month Return
- -19.56 %
- 1 Year Return
- -43.75 %
- 3 Year Return
- + 778.78 %
- 5 Year Return
- + 90.85 %
Summit Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Summit Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$11.9B
EPS (TTM)
-0.8598
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-874.7M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-192.51%
Summit Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Summit Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $11.9B | 90.85% | NA | 0.00% | NA | |
| BUY | $44.4B | 704.19% | NA | 0.00% | NA | |
| BUY | $132.8B | 172.51% | 28.9 | 35.00% | NA | |
| BUY | $83.2B | 27.56% | 19.42 | 27.87% | 0.45999999999999996% |
Stock Returns calculator for Summit Therapeutics Inc. Stock including INR - Dollar returns
The Summit Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Summit Therapeutics Inc. investment value today
Current value as on today
₹61,145
Returns
Returns from Summit Therapeutics Inc. Stock
Dollar Impact
₹4,948 (+4.95%)
Analyst Recommendation on Summit Therapeutics Inc. Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Summit Therapeutics Inc.. Average target price of $28.44
Summit Therapeutics Inc. Share Price Target
Get share price movements and forecasts by analysts on Summit Therapeutics Inc..
What analysts predicted
46.91%UPSIDE
Target Price
$28.44
Current Price
$15.1
Analyzed by
7 Analysts
Target
$28.44
Summit Therapeutics Inc. target price $28.44, a slight upside of 46.91% compared to current price of $15.1. According to 7 analysts rating.
Indian Investors' Interest in Summit Therapeutics Inc. Stock
Investment in Summit Therapeutics Inc. Shares on INDmoney has grown by 70.45% in the last 30 days, indicating increased investment activity.
Time period: to
Change:70.45% versus previous 30 day period
Search interest for Summit Therapeutics Inc. Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Summit Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Summit Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Summit Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Summit Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Summit Therapeutics Inc. News & Key Events

Today's Timeline - 24 July
Fri, 06:40 PM
-Summit reports Q2 2026 loss per share of 28 cents, wider than estimates, with no revenues recorded.
Fri, 09:23 PM
-Summit Therapeutics flags going concern risk due to insufficient cash for operations, raising doubts about its future viability.
Insights on Summit Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 7 days, SMMT stock has moved up by 11.5%
POSITIVE IMPACTBest in 3 Years

In the last 3 years, SMMT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers

In the last 1 year, Revolution Medicines, Inc. Common Stock has given 469.1% return, outperforming this stock by 512.9%
About Summit Therapeutics Inc.
| Organisation | Summit Therapeutics Inc. |
| Headquarters | 601 Brickell Key Drive, Miami, FL, United States, 33131 |
| Industry | Biotechnology |
| CEO | Mr. Robert W. Duggan |
| E-voting on shares | Click here to vote |
Key Management of Summit Therapeutics Inc.
Name | Title |
|---|---|
Mr. Nathan LiaBraaten | Senior Director of Investor Relations |
Dr. Wang Clow Fong ScD | Chief Biometrics Officer |
Mr. Robert W. Duggan | Co-CEO & Executive Chairman |
Mr. Manmeet Singh Soni CPA | COO, CFO & Director |
Mr. Bhaskar Anand | Chief Accounting Officer & Head of Finance |
Mr. Dave Gancarz CPA | Chief Business & Strategy Officer |
Dr. Urte Gayko Ph.D. | Chief Regulatory, Quality & Pharmacovigilance Officer |
Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-CEO, President & Director |
Prof. Kay Elizabeth Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
Dr. Elaine Carla Stracker J.D., Ph.D. | Chief Legal Officer |
FAQs
What is Summit Therapeutics Inc. share price today?
Summit Therapeutics Inc. share price today is $15.10 as on at the close of the market. Summit Therapeutics Inc. share today touched a day high of $15.75 and a low of $14.99.
What is the 52 week high and 52 week low for Summit Therapeutics Inc. share?
Summit Therapeutics Inc. share touched a 52 week high of $30.05 on and a 52 week low of $12.25 on . Summit Therapeutics Inc. stock price today i.e. is closed at $15.10,which is 49.75% down from its 52 week high and 23.27% up from its 52 week low.
What is Summit Therapeutics Inc.'s market capitalisation today?
Summit Therapeutics Inc. market capitalisation is $0.01T as on .
How to invest in Summit Therapeutics Inc. Stock (SMMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Summit Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Summit Therapeutics Inc. Shares that will get you 0.0993 shares as per Summit Therapeutics Inc. share price of $15.10 per share as on August 13, 2026 at 8:45 am IST.
What is the minimum amount required to buy Summit Therapeutics Inc. Stock (SMMT) from India?
Indian investors can start investing in Summit Therapeutics Inc. (SMMT) shares with as little as ₹95.32 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.20 in Summit Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Summit Therapeutics Inc. share’s latest price of $15.10 as on August 13, 2026 at 8:45 am IST, you will get 0.6623 shares of Summit Therapeutics Inc.. Learn more about
fractional shares .
What are the returns that Summit Therapeutics Inc. has given to Indian investors in the last 5 years?
Summit Therapeutics Inc. stock has given 90.85% share price returns and 28.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?